deal, page-11

boppy

Here are a couple of interesting links. You may have seen them already.

http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20090608005951&newsLang=en

http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20090723005788&newsLang=en

If all goes according to plan, these deals may work out alright for BOS. I'm assuming that the merger with GL Biochem, when it's all settled, will actually improve the CBTE SP. At the very least, one would think that the potential merger would already be factored in and be neutral.

As recently as July 2008 the CBTE SP was over $3.00. In early 2000 it actually peaked at over $20.00. So any improvement down the track will transfer to BOS SP.

Good from these levels of course ($0.02). Not so good for those who bought in above 10 cents.